| 23-10-2025 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            20,090 | 
            1.96 | 
            1.67 | 
            1.85 | 
            West Pharmaceutical Non-GAAP EPS of $1.96 beats by $0.27, revenue of $804.6M beats by $16.9M  [10/23/2025 6:08 AM] | 
            307.07 | 
            30.07  (10.86%) | 
            301.00 | 
            24.00  (8.66%) | 
            187.43 - 352.33 | 
            1,603,540 | 
            660,000 | 
            20,495 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 24-07-2025 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            15,730 | 
            1.84 | 
            1.51 | 
            1.52 | 
            West Pharmaceutical beats top-line and bottom-line estimates; updates FY25 outlook  [7/24/2025 6:02 AM] | 
            278.59 | 
            51.28  (22.56%) | 
            280.00 | 
            52.69  (23.18%) | 
            187.43 - 352.33 | 
            2,322,458 | 
            700,000 | 
            71,397 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 24-04-2025 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            15,550 | 
            1.45 | 
            1.22 | 
            1.56 | 
            West Pharmaceutical beats Q1 estimates  [4/24/2025 6:02 AM] | 
            210.09 | 
            -8.09  (-3.71%) | 
            223.00 | 
            4.82  (2.21%) | 
            187.43 - 394.42 | 
            2,248,215 | 
            1,140,000 | 
            1,533 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 13-02-2025 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            23,350 | 
            1.82 | 
            1.75 | 
            1.83 | 
            West Pharmaceutical beats Q4 top-line and bottom-line estimates; initiates FY25 outlook  [2/13/2025 6:02 AM] | 
            199.75 | 
            -122.52  (-38.02%) | 
            246.08 | 
            -76.20  (-23.64%) | 
            199.65 - 408.88 | 
            4,490,395 | 
            510,000 | 
            41,905 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 24-10-2024 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            20,780 | 
            1.85 | 
            1.51 | 
            2.16 | 
            West Pharmaceutical Non-GAAP EPS of $1.85 beats by $0.36, revenue of $746.9M beats by $37.29M  [10/24/2024 6:05 AM] | 
            331.20 | 
            44.76  (15.63%) | 
            325.00 | 
            38.56  (13.46%) | 
            265.00 - 413.70 | 
            1,731,777 | 
            770,000 | 
            20,356 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 25-07-2024 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            23,030 | 
            1.52 | 
            1.77 | 
            2.11 | 
            West Pharmaceutical Non-GAAP EPS of $1.52 misses by $0.21, revenue of $702.1M misses by $26.57M, lowers FY24 guidance  [7/25/2024 6:04 AM] | 
            278.07 | 
            -45.70  (-14.11%) | 
            282.00 | 
            -41.77  (-12.90%) | 
            265.00 - 415.73 | 
            3,062,742 | 
            610,000 | 
            112,203 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 25-04-2024 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            28,600 | 
            1.56 | 
            1.29 | 
            1.98 | 
            West Pharmaceutical beats Q1 top and bottom line consensus  [4/25/2024 6:01 AM] | 
            368.70 | 
            -17.03  (-4.42%) | 
            388.55 | 
            2.82  (0.73%) | 
            310.42 - 415.73 | 
            628,359 | 
            420,000 | 
            398 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 15-02-2024 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            29,490 | 
            1.83 | 
            1.78 | 
            1.77 | 
            West Pharmaceutical reports mixed Q4 results; initiates FY24 outlook  [2/15/2024 6:09 AM] | 
            351.56 | 
            -56.63  (-13.87%) | 
            339.95 | 
            -68.24  (-16.72%) | 
            272.79 - 415.73 | 
            2,943,958 | 
            550,000 | 
            49,821 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 26-10-2023 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            27,310 | 
            2.16 | 
            1.86 | 
            2.03 | 
            West Pharmaceutical Non-GAAP EPS of $2.16 beats by $0.30, revenue of $747.4M misses by $2.87M  [10/26/2023 6:05 AM] | 
            327.45 | 
            -30.55  (-8.53%) | 
            0.0 | 
            0.0  (0.00%) | 
            206.19 - 415.73 | 
            978,485 | 
            350,000 | 
            0 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 27-07-2023 | 
            PM | 
             | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            27,920 | 
            2.11 | 
            1.95 | 
            2.47 | 
            West Pharmaceutical Non-GAAP EPS of $2.11 beats by $0.18, revenue of $753.8M in-line  [7/27/2023 6:01 AM] | 
            354.49 | 
            -24.93  (-6.57%) | 
            380.00 | 
            0.58  (0.15%) | 
            206.19 - 389.39 | 
            897,099 | 
            320,000 | 
            171 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 27-04-2023 | 
            PM | 
            6:00 AM ET  (Apr 27) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            26,510 | 
            1.98 | 
            1.67 | 
            2.30 | 
            West Pharmaceutical Non-GAAP EPS of $1.98 beats by $0.31, revenue of $716.6M beats by $19.32M  [4/27/2023 6:02 AM] | 
            354.69 | 
            -2.54  (-0.71%) | 
            0.0 | 
            0.0  (0.00%) | 
            206.19 - 372.06 | 
            706,816 | 
            380,000 | 
            0 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 16-02-2023 | 
            PM | 
            6:00 AM ET  (Feb 16) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            20,440 | 
            1.77 | 
            1.39 | 
            2.04 | 
            West Pharmaceutical Non-GAAP EPS of $1.77 beats by $0.39, revenue of $708.7M beats by $51.54M  [2/16/2023 6:03 AM] | 
            319.19 | 
            40.01  (14.33%) | 
            294.00 | 
            14.82  (5.31%) | 
            206.19 - 424.00 | 
            1,402,927 | 
            670,000 | 
            438 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 27-10-2022 | 
            PM | 
            6:00 AM ET  (Oct 27) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            18,450 | 
            2.03 | 
            2.12 | 
            2.06 | 
            West Pharmaceutical Non-GAAP EPS of $2.03 misses by $0.09, revenue of $686.9M misses by $40.52M, updates FY guidance  [10/27/2022 6:09 AM] | 
            220.37 | 
            -34.03  (-13.38%) | 
            204.16 | 
            -50.24  (-19.75%) | 
            206.19 - 475.00 | 
            2,225,065 | 
            850,000 | 
            4,582 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 28-07-2022 | 
            PM | 
            6:00 AM ET  (Jul 28) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            23,230 | 
            2.47 | 
            2.19 | 
            2.46 | 
             | 
            339.75 | 
            19.23  (6.00%) | 
            320.52 | 
            0.0  (0.00%) | 
            275.89 - 475.35 | 
            728,730 | 
            380,000 | 
            23,315 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 28-04-2022 | 
            PM | 
            6:00 AM ET  (Apr 28) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            24,710 | 
            2.30 | 
            2.18 | 
            2.05 | 
            West Pharmaceutical Non-GAAP EPS of $2.30 beats by $0.18, revenue of $720M misses by $0.92M  [4/28/2022 6:09 AM] | 
            325.49 | 
            -6.87  (-2.07%) | 
            337.00 | 
            4.64  (1.40%) | 
            308.36 - 475.35 | 
            818,681 | 
            470,000 | 
            36,816 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 17-02-2022 | 
            PM | 
            6:00 AM ET  (Feb 17) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            28,420 | 
            2.04 | 
            1.92 | 
            1.34 | 
            West Pharmaceutical Non-GAAP EPS of $2.04 beats by $0.12, revenue of $730.8M beats by $20.6M  [2/17/2022 6:04 AM] | 
            387.27 | 
            7.95  (2.10%) | 
            379.32 | 
            0.0  (0.00%) | 
            253.85 - 475.35 | 
            535,457 | 
            360,000 | 
            16,584 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 28-10-2021 | 
            PM | 
            6:00 AM ET  (Oct 28) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            31,090 | 
            2.06 | 
            1.82 | 
            1.15 | 
            West Pharmaceutical EPS beats by $0.26, beats on revenue  [10/28/2021 6:11 AM] | 
            421.03 | 
            -0.31  (-0.07%) | 
            421.34 | 
            0.0  (0.00%) | 
            253.85 - 475.35 | 
            525,500 | 
            310,000 | 
            5,199 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 29-07-2021 | 
            PM | 
            6:00 AM ET  (Jul 29) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            27,930 | 
            2.46 | 
            1.74 | 
            1.25 | 
            West Pharmaceutical EPS beats by $0.72, beats on revenue  [7/29/2021 6:14 AM] | 
            405.28 | 
            21.27  (5.54%) | 
            384.01 | 
            0.0  (0.00%) | 
            253.85 - 407.00 | 
            664,256 | 
            330,000 | 
            15,530 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 29-04-2021 | 
            PM | 
            6:00 AM ET  (Apr 29) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            23,810 | 
            2.05 | 
            1.42 | 
            1.01 | 
            West Pharmaceutical EPS beats by $0.62, beats on revenue  [4/29/2021 6:04 AM] | 
            324.76 | 
            2.54  (0.79%) | 
            322.22 | 
            0.0  (0.00%) | 
            185.09 - 333.58 | 
            464,304 | 
            350,000 | 
            10,806 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 18-02-2021 | 
            PM | 
            6:00 AM ET  (Feb 18) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            21,740 | 
            1.34 | 
            1.13 | 
            0.82 | 
            West Pharmaceutical EPS beats by $0.21, beats on revenue and guides FY2021 earnings above consensus  [2/18/2021 6:05 AM] | 
            296.23 | 
            2.24  (0.76%) | 
            304.00 | 
            10.01  (3.40%) | 
            124.53 - 312.12 | 
            558,864 | 
            449,275 | 
            709 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 22-10-2020 | 
            PM | 
            6:00 AM ET  (Oct 22) | 
            WST | 
            West Pharmaceutical Services, Inc. | 
            21,570 | 
            1.15 | 
            1.01 | 
            0.79 | 
            West Pharmaceutical EPS beats by $0.16, beats on revenue  [10/22/2020 6:02 AM] | 
            279.11 | 
            -5.31  (-1.87%) | 
            287.00 | 
            2.58  (0.91%) | 
            124.53 - 303.14 | 
            454,878 | 
            355,579 | 
            448 | 
             | 
            
            
                | 
                
                 |